Evidence map›Paper›PMID 41090515›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Investigation into the Pancreatic Pathogenesis of SFTSV across Multiple Levels.

Xiaohan Liu, Zhihao Xu, Yilun Tong, Changtai Wang, Yueqi Yao, Yujie Diao, Jingyuan Ma, Shijun Zhou, Yinan Du, Zhenhua Zhang and 1 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Investigation into the Pancreatic Pathogenesis of SFTSV across Multiple Levels.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  5. Multidimensional mechanisms of SFTSV-host interactions: viral protein functions, mFrontiers in cellular and infection microbiology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Xiaohan LiuSchool of Basic Medical Sciences, Anhui Medical University, Hefei, 230032, China.
Zhihao XuThe First Clinical Medical School, Anhui Medical University, Hefei, 230032, China.
Yilun TongSchool of Basic Medical Sciences, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Changtai WangDepartment of Infectious Diseases, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230061, China.
Yueqi YaoSchool of Basic Medical Sciences, Anhui Medical University, Hefei, 230032, China.
Yujie DiaoDepartment of Blood Transfusion, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China.
Jingyuan MaSchool of Basic Medical Sciences, Anhui Medical University, Hefei, 230032, China.
Shijun ZhouDepartment of Infectious Diseases, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230061, China.
Yinan DuSchool of Basic Medical Sciences, Anhui Medical University, Hefei, 230032, China.
Zhenhua ZhangDepartment of Infectious Diseases, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230061, China.
Gang XuSchool of Basic Medical Sciences, Anhui Medical University, Hefei, 230032, China.ORCID https://orcid.org/0000-0003-0687-8108

Funding

Anhui institute of Translational Medicine Research Project No.2023zhyx-B10National Key Research and Development Program of China 2023YFC2606300Natural Science Foundation of Anhui Provincial 2308085Y49Postgraduate Innovation Research and Practice Program of Anhui Medical University YJS20240005
6 · The paper itself

Abstract

Severe Fever with Thrombocytopenia Syndrome virus (SFTSV) infection induces hepatitis, myocarditis, and even multi-organ dysfunction with a high mortality rate, while the impact on the pancreas remains unknown. In a retrospective analysis of clinical parameters in a cohort of 290 patients with severe fever with thrombocytopenia syndrome (SFTS), it is observed that pancreatic injury biomarkers in 19.4% (elevated serum amylase ≥3 × upper limit of normal (ULN)) and 25.8% (elevated serum lipase ≥3 × ULN). Notably, 17.6% of patients met the diagnostic criteria for clinically confirmed pancreatitis. Mechanistic studies using human pancreatic organoids and murine models demonstrated that SFTSV directly infects pancreatic tissue, facilitated by viral receptors C-C motif chemokine receptor 2 (CCR2) and lipoprotein receptor-related protein 1 (LRP1), provoking cell death in pancreatic tissue. Transcriptomic profiling revealed that SFTSV infection triggers a robust innate immune response characterized by interferon pathway activation and pro-inflammatory cytokine upregulation. Pathological analysis of infected murine pancreatic tissues showed acinar cell vacuolization, viral inclusions, and immune cell infiltration. Comparative studies with caerulein-induced pancreatitis models identified C3-mediated complement hyperactivation as a key pathological driver. The studies identified that SFTSV exhibits a specific pancreatic tropism, with direct infection leading to cell death and initiating a strong inflammatory immune response, resulting in viral pancreatitis.

Indexed as

PancreasPancreatitisAnimalsDisease Models, AnimalFemaleHumansMaleMiceMiddle AgedRetrospective Studiespancreatic tropismsevere fever with thrombocytopenia syndrome virustick‐borne infectious diseasesviral hemorrhagic feverviral pancreatitis

Identifiers

PMID41090515
PMCPMC12767103

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.